INSTITUTE MANAGEMENT. On June 1 Sven Enerbäck will become the new head of the Institute of Biomedicine. The new deputy head of the institute, Marianne Quiding-Järbrink, had already assumed her position on April 1. In an interview with Akademiliv, the new management duo note that they are taking over the management of a very well-run institute. Several colleagues passed the word to both Marianne and Sven that they would like…
Fredrik Sterky has synapses on his mind
YOUNG RESEARCHERS. Fredrik Sterky is home in Gothenburg again after postgraduate studies in Stockholm and a postdoc at Stanford. He is a resident physician in clinical chemistry, with a research interest in the connections among nerve cells in the brain. He has research time in the Wallenberg Centre for Molecular and Translational Medicine (WCMTM) and was recently one of the few young researchers in Gothenburg who received establishment support in…
Senior researcher grants from the Swedish Cancer Society to Eva Angenete and Fredrik Bergh Thoren
GRANTS. Eva Angenete, a researcher in cancer surgery, and Fredrik Bergh Thoren, who is conducting research in immunotherapy for cancer, have recently been notified that they are receiving several years of funding from the Swedish Cancer Society. The fundraising organization has chosen to give them the Senior Clinical Investigator Award and Senior Investigator Award respectively. Eva Angenete, an associate professor of surgery at the Institute of Clinical Sciences and chief…
New biomarkers for neuroblastoma, a type of cancer in children
NEW STUDY. Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment. “There is a need for new methods of treatment for high-risk patients, and that’s where our research can lead to truly great benefits,” says Chandrasekhar Kanduri, professor of…
Fast-acting antidote in sight for cholera epidemics
NEW STUDY. Groundbreaking discoveries regarding the onset of cholera are paving the way for a future, fast-acting antidote for cholera epidemics, according to research published in the journals PLOS Pathogens and ACS Infectious Disease. “This is not about a vaccine but rather a drinkable protection that can be distributed during an ongoing cholera epidemic to reduce its spread, a drink that blocks the cholera toxin so that it doesn’t…